Aethlon outlines Cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances



Aethlon outlines Cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances



Source link

You may be interested

Leave a Reply

Your email address will not be published. Required fields are marked *